市场调查报告书
商品编码
1451734
2024-2032 年按组件、产品、类型、交付模式、型号、应用和区域分類的临床决策支援系统市场报告Clinical Decision Support Systems Market Report by Component, Product, Type, Delivery Mode, Model, Application, and Region 2024-2032 |
2023年,全球临床决策支援系统(CDSS)市场规模达到16亿美元。展望未来, IMARC Group预计到2032年市场规模将达到30亿美元,2024-2032年CAGR为6.72%。对服务导向的智慧医疗决策软体的需求不断增长以及医疗错误事件的增加是推动市场发展的一些关键因素。
临床决策支援系统 (CDSS) 是一种基于电脑的专门资讯应用程序,旨在分析电子健康记录 (EHR) 记录系统中的资料。它提醒临床医生、医师和工作人员提出更好的临床治疗建议,以实现有效的病患照护。它采用各种基于硬体和软体的解决方案,例如云端存储,有助于管理和储存大量可存取的临床和管理资料。 CDSS 透过利用有针对性的临床和健康相关资讯做出复杂的医疗决策,简化工作流程,抑制用药错误的风险,减少误诊,并帮助执行各种行政操作,从而帮助增强医疗保健服务。除此之外,它还管理医疗实践,提供可靠的资讯和观察结果,并优化整体营运效率。因此,医院和诊所使用 CDSS 来提供药物过敏警报,并透过为患者提供特殊护理来确保更好的临床结果。
对具有专门演算法、互动介面和服务导向的架构的各种先进系统(包括治疗多种慢性疾病的 CDSS 解决方案)的需求不断增长,这主要推动了市场的成长。与此一致的是,由于人为干预导致的用药错误事件不断升级,加剧了 CDSS 在医疗保健领域的广泛采用,以做出更好的临床决策,这是另一个成长诱导因素。此外,各国政府为促进医院环境中卫生资讯和通讯技术(HICT)的采用而采取的有利措施也有利于市场成长。此类产品为卫生工作者提供可靠的资料,有助于以较低的支出为患者提供高品质的照护。此外,人工智慧(AI)、机器学习(ML)、电脑化供应商订单输入(CPOE)和统计模式识别解决方案的大规模集成,用于分析资料测量以提取信息,正在推动市场成长。这些技术可以透过多种消费性电子设备进一步管理,例如桌上型电脑、平板电脑、生物识别监控系统和穿戴式设备,这推动了市场的成长。除此之外,医疗保健基础设施的显着增强、消费者对其可用性和有益特性的认识不断增强,以及主要参与者之间持续进行的併购(M&A) 来设计先进的CDSS 解决方案,都为市场创造了积极的前景。
The global clinical decision support systems (CDSS) market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a CAGR of 6.72% during 2024-2032. The increasing demand for service-oriented intelligent healthcare decision-making software and the rising instances of medical errors represent some of the key factors driving the market.
The clinical decision support system (CDSS) refers to a specialized information computer-based application designed to analyze data within electronic health record (EHR) record systems. It provides reminders to clinicians, physicians, and staff to suggest better clinical treatments for effective patient care. It employs various hardware and software-based solutions, such as cloud storage, which helps manage and store an excessive amount of accessible clinical and administrative data. CDSS assists in enhancing healthcare delivery by making complex medical decisions with targeted clinical and health-related information, streamlines the workflow, inhibits the risk of medication errors, reduces misdiagnoses, and helps in executing diverse administrative operations. Apart from this, it manages medical practices, provides reliable information and observations, and optimizes overall operational efficiency. As a result, CDSS is used by hospitals and clinics to provide drug allergy alerts and ensure better clinical outcomes by providing exceptional care to patients.
The increasing need for various advanced systems with specialized algorithms, interactive interfaces, and service-oriented architectures, including CDSS solutions to treat several chronic disorders, is primarily driving the market toward growth. In line with this, the escalating instances of medication errors due to human intervention have intensified the widespread adoption of CDSS in the healthcare sector to make better clinical decisions, which is acting as another growth-inducing factor. Additionally, favorable initiatives undertaken by governments of various countries to promote the uptake of health information and communication technology (HICT) in hospital settings are favoring the market growth. Such products help provide high-quality care to patients at lower expenditure by furnishing health workers with reliable data. Moreover, the large-scale integration of artificial intelligence (AI), machine learning (ML), computerized provider order entry (CPOE), and statistical pattern recognition solutions to analyze data measurements for extracting information is propelling the market growth. These technologies can be further administered through multiple consumer electronic devices, such as desktops, tablets, biometric monitoring systems, and wearable devices, which is impelling the market growth. Apart from this, significant enhancements in the healthcare infrastructure, growing consumer awareness regarding its availability and beneficial properties, and ongoing mergers and acquisitions (M&A) amongst key players to engineer advanced CDSS solutions are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each segment of the clinical decision support systems (CDSS) market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on component, product, type, delivery mode, model, and application.
Hardware
Software
Services
The report has provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the component. This includes hardware, software and services. According to the report, services represented the largest segment.
Integrated CDSS
Standalone CDSS
A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the product has also been provided in the report. This includes integrated and standalone CDSS. According to the report, integrated CDSS accounted for the largest market share.
Therapeutic
Diagnostic
The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the type. This includes therapeutic and diagnostic. According to the report, therapeutic represented the largest segment.
On Premise
Cloud Based
A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the delivery mode has also been provided in the report. This includes on premise and cloud based. According to the report, on-premise accounted for the largest market share.
Knowledge Based
Non-Knowledge Based
The report has also provided a detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the model. This includes knowledge and non-knowledge based. According to the report, knowledge based represented the largest segment.
Drug Allergy Alerts
Clinical Guidelines
Drug-Drug Interactions
Clinical Reminders
Others
A detailed breakup and analysis of the clinical decision support systems (CDSS) market based on the application has also been provided in the report. This includes drug allergy alerts, clinical guidelines, drug-drug interactions, clinical reminders and others. According to the report, drug allergy alert accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for clinical decision support systems. Some of the factors driving the North America clinical decision support system market included the increasing demand for service-oriented intelligent healthcare decision-making software and the rising instances of medical errors.
Competitive Landscape
The report has also provided a comprehensive analysis of the competitive landscape in the global clinical decision support system market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Athenahealth Inc., Change Healthcare (United Health Group Incorporated), Epic Systems Corporation, General Electric Company, International Business Machines Corporation, Koninklijke Philips N.V., NextGen Healthcare Inc., Oracle Corporation, Siemens Healthineers AG (Siemens AG), Wolters Kluwer N.V., Zynx Health Incorporated (Hearst Business Media Corporation), etc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report